Gene variations alter risk of esophageal cancer

November 06, 2008

HOUSTON - Variations in a common gene pathway may affect esophageal cancer risk, a dangerous and rapidly increasing type of cancer, according to research by scientists at The University of Texas M. D. Anderson Cancer Center.

Results of the study, which is the first to look at the association between variations in genes related to microRNAs (miRNAs) and esophageal cancer, are published in the November issue of Cancer Prevention Research, a journal of the American Association of Cancer Research.

"Previous research has shown miRNAs control approximately one-third of human genes and may play a part in cancer risk," said the study's lead author, Xifeng Wu, M.D., Ph.D., a professor in the Department of Epidemiology at M. D. Anderson. "But whether genetic variants of miRNA-related genes influence esophageal cancer has largely remained unknown."

To examine the potential roles of these variations in esophageal cancer, researchers looked at the relationships among 41 single-nucleotide polymorphisms (SNPs) in 26 miRNA-related genes and risk of esophageal cancer. SNPs are places in the human genome that vary by a single DNA chemical building block or nucleotide.

Seven genotypes were significantly associated with esophageal cancer risk, and four more showed at least a borderline significance. The risk of esophageal cancer became higher in correlation to an increase in the number of the unfavorable genotypes present.

"This research showed not only that a single gene contributes to the risk of esophageal cancer, but more importantly that the joint effect of several genetic elements can increase risk," said the study's first author, Yuanqing Ye, Ph.D., an instructor in the Department of Epidemiology at M. D. Anderson.

Esophageal cancer ranks sixth in cancer-related deaths worldwide, and it is becoming more common. According to the American Cancer Society, more than 16,000 people will be diagnosed and more than 14,000 people will die of the disease in the United States this year.

"Incidence of esophageal cancer has increased six-fold in the past three decades, and the survival rate is poor," Wu said. "MicroRNAs are exciting because they can modulate the expression of so many human genes."

Major risk factors for esophageal cancer include tobacco smoking, alcohol consumption and reflux disease. The high prevalence of these risk factors in the general population and rare occurrence of this disease provide a clue that genetic predisposition to the disease may play an important role.

Researchers recruited 346 people who were newly diagnosed with esophageal cancer at M. D. Anderson and matched them by age, gender and ethnicity to 346 people without cancer. Only results for Caucasians were reported because of the low numbers of other races that enrolled.

While patients tended to be current smokers and have higher body mass index (BMI), there was no difference between the two groups in alcohol consumption.

One of the most notable findings was a SNP in the mir423 region, which was associated with a significantly lower esophageal cancer risk. The protective effect was significant for smokers and nonsmokers 64 years old and younger, but not for older subjects.

Mir423 also is found in leukemia cells and is altered significantly in other diseases including heart disease and Alzheimer's disease.

Future large-scale, multi-center studies are necessary to confirm these findings, Wu said.

"Our ultimate goal is to construct a comprehensive risk prediction model that includes not only genetic factors, but epidemiological and clinical variables as well, in hopes of predicting the probability of developing esophageal cancer in general population," she said.

University of Texas M. D. Anderson Cancer Center

100 Questions & Answers About Esophageal Cancer, 2nd Edition
by Pamela K. Ginex (Author), Maureen Jingeleski (Author), Bart L. Frazzitta (Author), Manjit S. Bains (Author)

The only reference to provide both the patient s and doctor s views, 100 Questions & Answers About Esophageal Cancer, Second Edition aims to provide a much needed primer for patients and their families and aims to address the questions most relevant to patients following a diagnosis of esophageal cancer. This text gives up-to-date, authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. Written by two oncology nurses and a gastric surgeon, with extensive commentary from an esophageal cancer survivor, and new information on cancer therapies, this book is an invaluable resource for anyone coping with the physical and emotional turmoil of this frightening disease.

John Hopkins Patients' Guide to Cancer of the Stomach and Esophagus (Johns Hopkins Medicine)
by Mark D. Duncan (Author)

Johns Hopkins Patients' Guide to Cancer of the Stomach and Esophagus is a concise, easy-to-follow how to guide that puts you on a path to wellness by explaining stomach and liver cancer treatment from start to finish. It guides you through the overwhelming maze of treatment decisions, simplifies the complicated schedule that lies ahead, and performs the task of putting together your plan of care in everyday terms. Empower yourself with accurate, understandable information that will give you the ability to confidently participate in the decision making about your care and treatment.

Esophageal Cancer: Principles and Practice
by Blair Jobe MD (Author), Thomas Charles MD (Author), Dr. John Hunter MD (Author)

Gastroesophageal cancers are the most common form of cancer incidents, and the second most common cause of death among cancer patients. In 2000, it was estimated that over one million new cases of gastroesophageal cancers were diagnosed worldwide, and over 900,000 individuals died from the disease. Using a multi-disciplinary approach, Esophageal Cancer: Principles and Practice addresses the complexities encountered in the understanding and management of esophageal cancers. Written by the world s leading experts in surgery, medical oncology, radiation oncology, gastroenterology, pathology, radiology, nutrition, nurse specialists, palliative medicine, and research relating to neoplasia of the esophagus, this text will serve as the definitive resource and enable practitioners to provide the...

100 Questions & Answers About Esophageal Cancer
by Pamela K. Ginex (Author), Manjit S. Bains (Author), Jacqueline Hanson (Author), Bart L. Frazzitta (Author)

This book gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. Written by three esophageal cancer experts and an actual patient.

Journeys through Cancer and Faith
by United Writers Press

The parallel journeys of two men who faced the diagnosis of esophageal cancer and found their own unique paths to a strengthened faith. In two different styles, Ed (Stage 2) and Bill (Stage 4) relate their individual stories, including how they met in an online support group and became friends. Honest, practical, and inspirational for those living with cancer and those who love them.

Esophageal Cancer: Current and Emerging Trends in Detection and Treatment (Cancer and Modern Science)
by Janey Levy (Author)

Esophagectomy Post Surgical Guide: Questions and Answers
by Esophageal Cancer Education Foundation (Author)

THE ESOPHAGEAL CANCER EDUCATION FOUNDATION The Esophageal Cancer Education Foundation (ECEF) www.fightec.org was formed in 2003 by Bart and Virginia Frazzitta. The initial purpose in establishing this 501 C 3 non-profit Organization was to help solicit funds for a CD ROM Project they had committed to fund for Memorial Sloan-Kettering Cancer Center. The project had a cost of $75,000. This was achieved and it served as the beginning of this Foundation geared to focus on a mission statement that covered three goals, namely: • To bring awareness and educate the public and medical community about this disease • To walk the journey with caregivers and with patients who have this disease • To support research projects that will lead to a test for early detection of this disease and...

Current State of Endoscopic Therapies in Barrett's Esophagus and Esophageal Cancer (DOI: 10.3810/hp.2011.02.388) (Postgraduate Medicine)
by JTE Multimedia

Barrett’s esophagus (BE) is a premalignant condition that predisposes patients to esophageal adenocarcinoma. This risk increases with increasing dysplasia, especially in patients with BE and high-grade dysplasia. Radical esophagectomy had long been the only option for these patients; however, it has been associated with significant morbidity and mortality. Endoscopic therapies have been increasingly used as an alternative to radical esophagectomy given the minimally invasive nature and tolerability of the procedure relative to surgery. Currently, the most widely used endoscopic therapies include endoscopic mucosal resection, photodynamic therapy, CryoSpray ablation, and radiofrequency ablation. Retrospective and prospective studies on the use of each of these modalities in patients with...

Esophageal Stents for the Treatment of Malignant Dysphagia in Patients with Esophageal Cancer (Postgraduate Medicine)
by JTE Multimedia

Abstract: Self-expanding metal stents (SEMS) are the current standard for relief of malignant esophageal dysphagia. Self-expanding plastic stents (SEPS) are also used for relief of malignant esophageal dysphagia and as neoadjuvant therapy due to their relative ease of removability. The innovations in design of both SEMS and SEPS have made their use more prevalent in patients with malignant dysphagia. We review the current literature on esophageal stents, including general concepts, indications, contraindications, SEMS and SEPS models, complications and their management, implications of tumor location, cost-effectiveness of stents in comparison with other modalities, and quality of life after stent placement.

Treatment of Esophageal and Hypopharingeal Squamous Cell Carcinoma (Updates in Surgery)
by Giovanni De Manzoni (Editor)

Squamous cell carcinoma of the esophagus has a lower incidence than other gastrointestinal tract cancer; however, there are many difficult issued related to the choice of appropriate therapy for these patients. In recent years, the use of multimodal treatment has greatly improved the prognosis of patients affected by this disease but several aspects of the oncological and surgical management are still controversial. This book aims to give a homogeneous approach to esophageal cancer treatment, based on the author’s lifetime experience in conjunction with exhaustive review of recent literature. In each chapter surgeons and oncologists will find appropriate tools for correct management of the diagnosis and therapy of this difficult disease. The book analyzes all the aspects of staging and...